Barequet I S, Soriano E S, Green W R, O'Brien T P
Wilmer Eye Institute, Johns Hopkins Hospital, Baltimore, Maryland 21287, USA.
J Cataract Refract Surg. 1999 May;25(5):626-31. doi: 10.1016/s0886-3350(99)00004-8.
To compare the efficacy of a single application of lidocaine 2% gel with tetracaine 0.5% drops for topical anesthesia in clear corneal cataract surgery.
The Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
A preliminary toxicity study applied lidocaine 2% gel in the conjunctival fornices of rabbit eyes (n = 9). Biomicroscopic examination was performed and then enucleation at sequential intervals after the application. Intentional intracameral injection of lidocaine gel was performed (n = 3), followed by enucleation. Histopathological analysis was performed on all eyes. A randomized clinical trial comparing topical anesthesia in clear corneal cataract surgery was performed in 25 eyes of 25 patients (12 eyes randomly assigned to lidocaine gel, 13 eyes to tetracaine drops). Corneal sensation was measured with the Cochet-Bonnet aesthesiometer before application of the topical anesthesia, 5 minutes after application, and at the conclusion of surgery. Additional intraoperative local anesthesia and systemic sedation were recorded. Patients' subjective level of comfort was reported 20 minutes after surgery, and the surgeon's perception of patients' comfort was also noted.
In rabbits, lidocaine gel did not cause clinical or histopathological alteration of the ocular tissues. In the clinical study, median corneal sensitivity before application, after 5 minutes, and postoperatively was 6, 0, 0 (maximum sensitivity = 6), respectively, in the lidocaine gel group and 5, 0, 0, respectively, in the tetracaine drops group. Additional local anesthesia was administered in 17% and 31% of patients, respectively. Satisfactory comfort was reported by 58% in the lidocaine gel group and 62% in the tetracaine drops group.
A single application of lidocaine 2% gel was a safe and effective alternative to multiple topical anesthetic drops for clear corneal cataract surgery. Lidocaine 2% gel was similar to tetracaine drops in provision of corneal anesthesia and patient comfort, while causing no significant toxicity to the ocular surface.
比较2%利多卡因凝胶单次应用与0.5%丁卡因滴眼液用于透明角膜白内障手术局部麻醉的效果。
美国马里兰州巴尔的摩市约翰霍普金斯大学医学院威尔默眼科研究所。
一项初步毒性研究将2%利多卡因凝胶应用于兔眼结膜穹窿(n = 9)。应用后进行生物显微镜检查,随后在不同时间间隔进行眼球摘除。对3只兔眼进行前房内注射利多卡因凝胶,然后进行眼球摘除。对所有眼球进行组织病理学分析。在25例患者的25只眼中进行了一项比较透明角膜白内障手术局部麻醉的随机临床试验(12只眼随机分配至利多卡因凝胶组,13只眼分配至丁卡因滴眼液组)。在局部麻醉应用前、应用后5分钟以及手术结束时,使用科谢-博内眼压计测量角膜感觉。记录额外的术中局部麻醉和全身镇静情况。术后20分钟报告患者的主观舒适度,并记录外科医生对患者舒适度的感知。
在兔眼中,利多卡因凝胶未引起眼组织的临床或组织病理学改变。在临床研究中,利多卡因凝胶组应用前、5分钟后及术后角膜敏感性中位数分别为6、0、0(最大敏感性 = 6),丁卡因滴眼液组分别为5、0、0。分别有17%和31%的患者接受了额外的局部麻醉。利多卡因凝胶组58%的患者和丁卡因滴眼液组62%的患者报告舒适度满意。
对于透明角膜白内障手术,单次应用2%利多卡因凝胶是多次局部麻醉滴眼液的一种安全有效的替代方法。2%利多卡因凝胶在提供角膜麻醉和患者舒适度方面与丁卡因滴眼液相似,同时对眼表无明显毒性。